INS and metabolic disease: In metabolic disorders, an INI-induced increase in insulin levels and an improvement in the insulin signaling system in the hypothalamus lead to the restoration of mitochondrial functions, an increase in the survival of hypothalamic neurons, and a decrease in oxidative stress and neuroinflammation.